Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-04-29 Regulatory Filings
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2020-04-29 English
News release - English.pdf
Regulatory Filings
2020-04-16 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the annual filings for the financial year ended November 30, 2019. The text explicitly states it is a certification document under National Instrument 52-109, focusing on the accuracy and completeness of annual filings but does not contain actual financial statements or detailed financial data. It is primarily an officer certification letter, not the annual report or financial statements themselves. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the report they reference (e.g., 10-K or Annual Report). The document length is short (3163 characters), and it is a certification rather than a full report or announcement of a report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2020-04-04 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CFO. It certifies the review and fair presentation of annual filings including AIF, annual financial statements, and MD&A for the financial year ended November 30, 2019. The document is primarily an officer certification letter and does not contain actual financial data or the full annual report itself. It explicitly states it is a certification under National Instrument 52-109 and includes disclaimers about controls and procedures. The document length is short (3119 characters) and it is a certification rather than the report itself. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or Management Reports (MDA).
2020-04-04 English
Annual MD&A - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F1 Certification of Annual Filings by the Chief Financial Officer of AutoCanada Inc. It certifies the review and fair presentation of the annual filings including the annual financial statements and MD&A for the financial year ended December 31, 2019. The document focuses on the certification of disclosure controls and internal control over financial reporting (ICFR) as per National Instrument 52-109. It does not contain the actual annual report or financial statements but is a certification letter related to those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K). The document length is under 5,000 characters and is a standalone certification, not the full report itself.
2020-04-04 English
Audited annual financial statements – English.pdf
Regulatory Filings
2020-04-04 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.